The FDA has warned healthcare professionals about prescribing errors involving AstraZeneca's Seroquel quetiapine fumarate and Bristol-Myers Squibb's Serzone nefazodone hydrochloride. The medication errors resulted from a similarity in names, overlapping strengths (100 mg and 200 mg), dosage form tablets, the dosing interval BID, as well as the fact that both...
WILMINGTON, Del., May 14 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the U.S. Food and Drug Administration FDA has approved SEROQUELR quetiapine fumarate tablets for the maintenance treatment of patients with bipolar I disorder, as adjunct therapy to lithium or divalproex. SEROQUEL is approved by the FDA for the...
WILMINGTON, Del.--BUSINESS WIRE--September 29, 1997--Zeneca Pharmaceuticals today announced that the Food and Drug Administration FDA has cleared for marketing SEROQUELr quetiapine fumarate tablets, an oral medication indicated for the management of the manifestations of psychotic disorders, including schizophrenia. SEROQUEL is a new "atypical" antipsychotic agent in a new chemical...
ASTRAZENECA is investing $60 million in its manufacturing site at Macclesfield, northwest England, to meet growing demand for Seroquel ... ASTRAZENECA is investing $60 million in its manufacturing site at Macclesfield, northwest England, to meet growing demand for Seroquel quetiapine, its atypical antipsychotic...
WILMINGTON, Del., May 8 /PRNewswire-FirstCall/ -- AstraZeneca today announced the submission of a supplemental New Drug Application sNDA to the U.S. Food and Drug Administration FDA for SEROQUEL XRTM quetiapine fumarate Extended-Release Tablets to seek approval for the treatment of generalized anxiety disorder GAD, including maintenance of antianxiety...
AstraZeneca's tactic of growing profits by trimming costs and relying on its "five key products" continues to pay dividends. These products are stomach ulcer drug Nexium, psychiatric product Seroquel, cholesterol-lowering drug Crestor, asth AstraZeneca's tactic of growing profits by trimming costs and relying on its...
AstraZeneca's psychiatric drug, Seroquel, may worsen the symptoms of Alzheimer's disease. Study data published in the British Medical Journal suggests memory function deterioration doubled in Alzheimer's patients taking the drug, which is approved to AstraZeneca's psychiatric drug, Seroquel, may worsen the symptoms of Alzheimer's disease....
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53479) has announced the addition of the Decision Resources, Inc report: Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market? to their offering.
Question-and-Answer SessionOperator Ladies and gentlemen, the question-and-answer session will be conducted electronically. Operator Instructions Our first question will come from Ms. Alexandra Hauber with Bear Stearns. Please go ahead. Alexandra Hauber - Bear Stearns Yes, good afternoon. I have four questions please. David, could you speak a bit to...